30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Stryker Posts 2Q16 Revenue -

ORTHOWORLD estimates Stryker's 2Q16 orthopaedic revenue at US $1,555.9MM, +4.0% from 2Q15. (Growth is as-reported.)

ORTHOWORLD estimates 2Q16 segment sales and growth on an as-reported basis, as follows.

  • Joint Reconstruction $841.2MM, +3.8%
    • Hips $358.4MM, +2.6%
    • Knees $457.7MM, +4.8%
    • Extremities Recon $25.1MM, +2.8%
  • Trauma $303.4MM, +6.2%
  • Arthroscopy/Soft Tissue Repair $113.5MM, +5.5%
  • Spine $177.8MM, +0.9%
  • Orthobiologics $51.0MM, +4.1%
  • Other $69.0MM, +3.8% (CMF, Performance Solutions)


  • Growth buoyed by continued momentum for 3D-printed Tritanium revision cones, cementless knee products and strong ex-U.S. sales in knees
  • Too early to detect impact of CJR initiative on the market, per leadership
  • Placed 17 Mako units during the quarter (vs. 13 in 2Q15 and 7 in 1Q16)
  • 1588 AIM video platform contributed to AR/ST growth
  • Cited "good demand" for new 3D-printed Tritanium spine products, though spine growth impacted by continued challenges in China
  • Supply disruption that affected spine is expected to continue into 2H16, beginning to improve in 4Q16

Sources: Stryker Corp., ORTHOWORLD Inc., ORTHOWORLD estimates for orthopaedic-specific revenue

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.